Spheroids are widely used in biology because they provide an in vitro 3-dimensional (3D) model to study proliferation, cell death, differentiation, and metabolism of cells in tumors and the response of tumors to radiotherapy and chemotherapy. The methods of generating spheroids are limited by size heterogeneity, long cultivation time, or mechanical accessibility for higher throughput fashion. The authors present a rapid method to generate single spheroids in suspension culture in individual wells. A defined number of cells ranging from 1000 to 20,000 were seeded into wells of poly-HEMA-coated, 96-well, round-or conical-bottom plates in standard medium and centrifuged for 10 min at 1000g. This procedure generates single spheroids in each well within a 24-h culture time with homogeneous sizes, morphologies, and stratification of proliferating cells in the rim and dying cells in the core region. Because a large number of tumor cell lines form only loose aggregates when cultured in 3D, the authors also performed a screen for medium additives to achieve a switch from aggregate to spheroid morphology. Small quantities of the basement membrane extract Matrigel, added to the culture medium prior to centrifugation, most effectively induced compact spheroid formation. The compact spheroid morphology is evident as early as 24 h after centrifugation in a true suspension culture. Twenty tumor cell lines of different lineages have been used to successfully generate compact, single spheroids with homogenous size in 96-well plates and are easily accessible for subsequent functional analysis. (Journal of Biomolecular Screening 2006:922-932) 
INTRODUCTION
M ONOLAYER CELL CULTURES insufficiently reflect the physiological response pattern of the in vivo situation because of fundamental geometric differences between 2dimensional (2D) cultures and 3-dimensional (3D) solid tumors. A 3D architecture of tumor cells needs to be generated in vitro to simulate the multicellular microenvironment when investigating the tumor cell physiology and response to therapeutic agents. Multicellular tumor spheroids have been widely used as an in vitro 3D model over the past decades to study tumor cell proliferation, apoptosis, differentiation, gene expression, and metabolism in a multicellular context. Tumor spheroids are considered an improved in vitro model to mimic biological properties of micrometastases and vessel distal regions of tumors because they retain the architecture and many morphological and physiological characteristics of their tumor counterparts. 1, 2 Tumor cells in spheroids show a higher degree of morphological [3] [4] [5] and functional [6] [7] [8] [9] differentiation than cells grown in monolayer culture. They also display growth kinetics, 10, 11 metabolic rates, and resistance to radiotherapy and chemotherapy similar to tumor cells in vivo. [12] [13] [14] [15] [16] The increased cell-cell and cell-matrix contacts in compact spheroids not only alter gene expression patterns 17, 18 and resistance to antineoplastic treatment but also limit the diffusion of nutrients, oxygen, and waste products into and out of the spheroids. 2 This gives rise to a more stratified composition, with the rim of spheroids consisting of proliferating cells, followed by a layer of quiescent cells in the middle and necrotic cells in the center of the spheroid. 11 A similar cellular heterogeneity is present in nonvascularized tumor regions. 1, 19 Because monolayer-based high-throughput (HT) systems have only a limited predictive value for the in vivo efficacy of antineoplastic compounds, the implementation of the spheroid model in the drug discovery process may improve the predicted activity of new cancer drugs in cell-based screening assays. 20 Several approaches have been developed to enable drug screening using spheroids: confocal microscopy to measure drug or antibody permeation into the spheroid, 20,21 electrochemical microscopy to measure the respiratory activity, 22 image cytometry to quantify lactate dehydrogenase activity as a marker for cell viability, 23 or biosensors composed of spheroids monitoring physiological alterations by impedance measurements. 24 However, the use of spheroids in an HT fashion in oncology research requires a standardized protocol that rapidly generates spheroids of homogenous size with similar diffusion gradients and cell physiology in a plate format that is easily accessible for subsequent biochemical or cell analysis.
Various culture techniques are used to generate spheroids. 25 In the liquid-overlay technique, trypsinized cells are placed on dishes covered with a thin film of agar. 26 Because the coating prevents cell attachment to the dish, cells can grow only in 3D, and individual cells give rise to aggregates or spheroids. In the spinner flask 27 and the gyratory rotation technique, 28 trypsinized cells are placed in a culture vessel with a magnetic stirrer, inhibiting cell attachment to the substrate and favoring cell-cell adhesion. In a more recently developed technique, spheroids are grown in a hanging drop of an inverted microplate. 29 However, these methods are limited by either long cultivation time, formation of unequal-size spheroids, or difficult mechanical accessibility. In addition, in suspension cultures, many tumor cell lines grow poorly in 3D as compact spheroids. 1, 20 They form loose aggregates of cells only, an architecture that is significantly different from the in vivo tumor morphology.
To use tumor spheroids in an HT format, we developed a simple protocol for rapid production of homogenous multicellular tumor spheroids even from aggregate-forming cell types. In this study, we demonstrate that single, compact spheroids with homogeneous sizes can be generated rapidly and in large scale in 96-well microplates as suspension cultures. Moreover, this technique is applicable to a large variety of tumor cell lines.
MATERIALS AND METHODS

Cell culture
The following breast cancer cell lines were applied to establish a protocol for rapid spheroid generation in a 96-well format: MDA-MB-231 (ATCC HTB 26), MDA-MB-468 (ATCC HTB 132), SK-BR-3 (ATCC HTB 30), T-47D (ATCC HTB 133), MCF7 (ATCC HTB 22), MCF7-ADR (Balcer-Kubiczek et al.), and MDA-MB-435S (ATCC HTB 129, which might be of melanoma origin if spontaneous transdifferentiation event can be excluded). In addition, the optimal protocol was tested in the following cell lines: UO-31 (NCI), HEK 293 (ATCC CRL-1573), SK-OV-3 (ATCC HTB 77), IGR-OV-1 (NCI), NCI-H460 (HTB 177), NCI-H322M (NCI), A549 (ATCC CCL 185), PC-3 (ATCC CRL 1435), LNCaP (ATTC CRL 1740), Colo 205 (ATCC CCL 222), SW-620 (CCL 227), HCT-15 (ATCC CCL 225), and HepG2 (ATCC HB 8065). All cells were cultured in RPMI 1640 (PAA Laboratories GmbH, Innsbruck, Austria) with 10% fetal calf serum (FCS; Gibco-BRL, Karlsruhe, Germany) and 2 mM L-glutamine (Gibco-BRL), with the exception of SK-BR-3 cells, which were cultivated in McCoy's 5A (Gibco-BRL) with the same medium supplements.
Screen for medium additives to induce spheroid formation from aggregates
MDA-MB-231 cells grown as a monolayer were detached with Accutase (PAA Laboratories GmbH), and 5000 cells were distributed into single wells of round-bottom, 96-well plates (Corning Inc., New York, NY). To prevent cell attachment, the plates were precoated with 50 µl 0.5% poly-HEMA (Polysciences, Eppelheim, Germany) in 95% ethanol and air dried at 37° C for 3 days prior to use. The cells were pelleted at the bottom of the wells by centrifugation of the plates at 1000g for 10 min using a swinging bucket Eppendorf 5810 centrifuge (Eppendorf AG, Hamburg, Germany). For optimal spheroid formation, the following additives were tested: reconstituted basement membrane (rBM; BD Biosciences, Bedford, MA) at 5, 15, 25, 35, and 75 µl/ml and collagen type I (Roche Diagnostics GmbH, Mannheim, Germany), collagen type IV (Fluka, Taufkirchen, Germany), fibronectin (Roche Diagnostics GmbH), and laminin (Roche Diagnostics) at 1, 5, 10, 25, 100, and 500 µg/ml. Heparan sulphate proteoglycane (Sigma-Aldrich, Deisenhofen, Germany) and chondroitin sulphate (Sigma-Aldrich) were tested at 1, 5, and 10 µg/ml. The single additives or combinations were added after centrifugation directly into the wells. The plates were incubated under standard cell culture conditions at 37°C, 7% CO 2 in humidified incubators.
Generation of spheroids
Cells grown as a monolayer were detached with Accutase to generate a single-cell suspension. The cell number was determined using a CASY particle counter instrument (Schaerfe-Systems, Reutlingen, Germany). The cell suspension was diluted to 2.5 × 10 4 (for 5000 cells per spheroid) or 5 × 10 4 (for 10,000 cells per spheroid) cells per milliliter of ice-cold medium. The rBM was thawed on ice overnight and added at a final concentration of 2.5% with ice-cold pipette tips to the cell suspension. A volume of 200 µl of this cell suspension was added to each well of a poly-HEMA-coated 96-well plate with a round or conical bottom (Nunc, Roskilde, Denmark). The spheroid formation was initiated by centrifugation of the plates at 1000g for 10 min. The plates were incubated under standard cell culture conditions at 37°C, 7% CO 2 in humidified incubators.
Assessment of spheroid cell apoptosis
Spheroids were generated from 8 breast cancer cell lines using 10,000 cells per spheroid. All cell lines except MCF7 and T-47D were grown in the presence of 2.5% rBM. For apoptosis analysis, the spheroids were transferred into a 96-well conicalbottom plate, washed once with phosphate-buffered saline (PBS), resuspended in Accutase solution, and incubated at 37° C. Every 5 min, the spheroids were resuspended by pipetting, and dissociation was almost complete within 15 to 20 min. The single-cell suspensions from the 8 spheroids were pooled, and cells were stained with annexin-V-fluos and propidium iodide in the prescence of supplemented 2 mM CaCl 2 (annexin-V-fluos staining kit; Roche Diagnostics GmbH). The fluorescence from 10,000 cells was acquired using a fluorescence-activated cell sorting (FACS) scan instrument (Becton Dickinson, San Jose, CA). Quadrant statistics was applied on the dot plots, with the number of viable cells located in the lower-left quadrant. To determine the absolute cell number of viable cells within growing spheroids, MDA-MB-231 spheroids were dissociated as described above. The number of total cells from 3 individual spheroids were counted using a CASY particle counter instrument and multiplied with the percentage of viable cells of the same spheroid as determined from the annexin-V assay.
Localization of cell death within spheroids
MDA-MB-231 spheroids were generated from 10,000 cells with the addition of 2.5% rBM. The spheroids were transferred into a 96-well, round-bottom plate and resuspended in 200 µl RPMI without rBM to reduce unspecific binding of propidium iodide (PI; Sigma-Aldrich) to the rBM. The spheroids were stained within the wells with 1 µg/ml PI for 3 h. The localization of PI-positive stained cells within the spheroids was assessed by phase contrast and PI fluorescence microscopy of superimposed images.
Hematoxylin and eosin stain of spheroid slices
MDA-MB-231 spheroids generated from 10,000 cells in the presence of 2.5% rBM prior staining were cultivated for 3 days, washed once in PBS, fixed overnight with 4% formalin (Merck, Darmstadt, Germany), and embedded in paraffin. Microtone (Leica, SM, 2000R) sections of 5 µm were placed on SuperFrost glass slides (Menzel, Braunschweig, Germany) and allowed to dry for 2 h at 37° C. The sections were deparaffinized by 3 changes of xylol for 5 min, rehydrated by 2 changes of 100% ethanol, followed by 80% ethanol and 2 washes in 70% ethanol for 2 min each. After a short single rinse in distilled water, the sections were stained for 20 min in Mayer's hematoxylin (Merck) and placed for 20 min under running tap water. Sections were counterstained with eosin (Merck) for 4 min, dehydrated by 2 changes of 70% ethanol, followed by 1 change to 80% ethanol, 1 in 100% ethanol for 2 min each, and 2 changes of xylol for 5 min. The slides were mounted in Eukitt (KO Kindler, Germany), and spheroid sections were assessed by bright field microscopy.
Immunoblotting of cell membrane proteins
MDA-MB-231 spheroids were generated in the presence of 2.5% rBM and harvested after 1 and 10 days. Spheroids from one 96-well plate were pooled, washed twice with ice-cold PBS, and solubilized in 200 µl lysis buffer (50 mM HEPES, pH 7.5, 150 mM NaCl, 1.5 mM MgCl 2 , 100 mM NaF, 10 mM NaPyrophosphat, 1 mM EDTA, 10% glycerol, 1% Triton X100, 0.4 mM Na 3 VO 4 , 10 µM PMSF, 10 µg/ml aprotinin). Lysates were shaken for 30 min at 4° C and centrifuged for 15 min at 15,000 rpm. The protein concentration was determined using the BCA protein assay kit (Pierce, Rockford, IL). A total of 20 µg protein extract was mixed with 4× loading buffer (Invitrogen, Carlsbad, CA), resolved on a 4% to 12% denaturing Bis-Tris Gel (Invitrogen), and transferred with 50 mM Tris, 40 mM glycin, 20% methanol, and 0.04% sodium dodecyl sulfate in a semidry blot chamber (BioRad Laboratories, Hercules, CA) for 1 h and 120 mA (for 117 cm 2 ) onto a nitrocellulose membrane. Immunostaining of the proteins was performed with the LumiLight PLUS Western Blotting Kit (Roche Diagnostics) according to the manufacturer's instructions. Human integrin β1, claudin 4, and β-actin were probed using anti-integrin β1 (BD Biosciences), anticlaudin-4 (Zymed Laboratories, South San Francisco, CA), and anti-βactin (Abcam, Cambridge, UK)-specific antibodies.
Determination of spheroid growth kinetics
MDA-MB-231 spheroids were generated from 1000 and 10,000 cells in the presence of 2.5% rBM. Monolayer cultures were generated by seeding each 5 × 10 4 cells into single wells of a 6-well plate. 5-bromo-2-deoxy-uridine (BrdU; Sigma-Aldrich) was added at 8 × 10 -5 M to cell cultures. Spheroids were harvested daily up to 10 days, monolayer control cultures were harvested daily up to 3 days, and BrdU was added for the final 24 h at each time point to determine the nonproliferating, resting G1 cells and dividing cells. The harvested cells were centrifuged and resuspended in 500 µl DNA staining buffer (100 mM Tris-HCl, pH 7.4, 0.9% NaCl, 1 mM CaCl 2 , 0.5 mM MgCl 2 , 0.2% bovine serum albumin, 0.1% NP40) supplemented with 60 U/ml RNAse (Calbiochem, Darmstadt, Germany). The buffer lysed the cytoplasmic but not the nucleus membrane. The nuclei were stained with 1.5 µg/ml Hoechst 33258 (Sigma-Aldrich) for 15 min on ice in the dark and counterstained with 2 µg/ml PI for another 15 min. The DNA fluorescence of the nuclei was recorded from 10,000 cells using a FACS LSR instrument (Becton Dickinson). Region-of-interest gating was applied to identify noncycling G1 cells and slowly cycling and rapidly dividing cells (see regions R1, R2, and R3 in Fig. 5 ).
Microscopy
The morphology of the spheroids was assessed and recorded using an Axiovert 135 Microscope (Zeiss, Jena, Germany) and a 5× objective. Pictures were taken with a Xillix Microimager Camera (Xillix Technology Corporation, Richmond, Canada) using the Open Lab 2.2.5 Software (Improvision, Coventry, UK).
The size of the spheroids was analyzed using the calibration software analysis tools and an objective calibration slide (Zeiss).
RESULTS
Single spheroid formation in 8 breast cancer cell lines
To generate homogenous 3D culture spheroids from tumor cells in a screening format, we centrifuged 5000 cells in 96 roundor conical-bottom plates precoated with poly-HEMA to prevent cell attachment. The plates were centrifuged for 10 min at 1000g. During the centrifugation, all cells within the well are pelleted at the bottom of the plate. This ensures equal cell numbers for initiation of the formation of a single spheroid in each well of a 96-well plate. We evaluated a panel of 8 breast cancer cell lines according to their ability to form spheroids in microplates. As shown in Figure 1 , 3 cell lines, MCF7, T-47D, and MDA-MB-435, form multicellular spheroids within 24 h of cultivation. The spheroids formed by MCF7 and T-47D cells are highly compact ( Fig. 1A, B) , whereas MDA-MB-435 cells are incorporated into a spheroid with loosely associated cells at the periphery (Fig. 1C) .
The adriamycin-resistant cell line derived from MCF7 and MCF7-ADR reaches the spheroid morphology after 48 h of cultivation ( Fig. 1D) . Four cell lines, namely, MDA-MB-231, MDA-MB-468, SK-BR-3, and MDA-MB-361, form only loose aggregates of cells after 24 h ( Fig. 1E-H) . The cell-cell contacts established by these cultures are weak, and the aggregates can be easily dispersed mechanically by pipetting. This morphology observed initially did not change within 14 days of cultivation. We defined these latter cultures as loose aggregates in contrast to spheroids formed by MCF7 or T-47D cells.
Medium additives for induction and time kinetics of spheroid formation
To achieve a tighter spheroid-like 3D morphology, we performed a screen for medium additives using the aggregate-forming cell line MDA-MB-231. Fibronectin, laminin, and collagen type IV were tested at concentrations from 1 to 500 µg/ml, and heparan sulphate proteoglycane and chondroitin sulphate were applied at concentrations ranging from 1 to 10 µg/ml. Any single component added to cell aggregates did not alter the aggregate morphology up to 14 days of culture (representative examples are shown in Fig. 2A-D) . A preparation of collagen I from rat tail tendon partially increased the intercellular contacts of the MDA-MB-231 3D culture, with some evidence of tight local packaging ( Fig. 2E) . This effect was observed at and above a concentration of 10 µg/ml. A combination of 2, 3, or all components led to a partial compaction of the aggregate only in the presence of collagen I (data not shown). The optimal compaction status was achieved with liquid rBM as additive. At a concentration of 2.5% rBM, all cells were incorporated in 1 distinct spheroid with a round geometry (Fig. 2F) . Formation and compaction were completed after 24 h of culture time. Lower concentrations of rBM did not ensure the incorporation of all cells into the spheroid, and higher concentrations impaired the round geometry of the spheroids. Figure 3 shows the kinetics in spheroid formation of MDA-MB-231 cells without (A-D) and in the presence (E-H) of liquid reconstituted basement membrane (rBM). After the 10-min centrifugation step, all cells within the well are incorporated into 1 flat pellet of cells (Fig. 3A, E) . Three hours later, some degree of compaction becomes evident in both assay formats (Fig. 3B, F) . Without rBM, no further tightening of the aggregates can be observed after 6 and 24 h (Fig. 3C, D) . In contrast, the addition of rBM induces an ongoing compaction in MDA-MB-231 aggregates, and after 6 h, a tight cell association can be observed in the presence of rBM (Fig. 3G) . The forming spheroids show a reduction in diameter of almost 50% of the initial aggregate, and after 24 h, the spheroid formation is completed (Fig. 3H) . The spheroids retain their tight structure and do not disintegrate by pipetting as do their aggregate counterparts.
Characteristics of MDA-MB-231 spheroids induced by rBM additive
To investigate the effect of rBM on the tightness of the cell packaging in spheroids, we examined histological sections of MDA-MB-231 spheroids grown for 3 days in culture. Figure 4A shows an H&E stain from the rim section of the top of a spheroid. It is evident that the cell density of MDA-MB-231 cells is high in this region. Figure 4B displays an H&E stain of a middle section of a spheroid encompassing rim and center structures. It is obvious that the rim of the spheroid consists of about 4 to 6 cell layers of tightly packed cells. Toward the center, the cells are less densely packed, most probably because of onging cell death (see also Fig. 8A, B) .
To evaluate the similarity of cell-cell adhesions of spheroids generated rapidly with the centrifugation technique compared to spheroids grown from a few cells over extended periods of time, we investigated the expression patterns of adhesion and tight junction proteins of 24-h spheroids derived from 10,000 cells with 10-day-old spheroids derived from 1000 cells: integrin β1 and claudin 4. The Western blot in Figure 4C reveals that there was no difference in the expression patterns of these proteins in the different culture setups (loading control β-actin). 
Growth kinetics of MDA-MB-231 spheroids
To determine whether cells in spheroids generated by centrifugation exhibit a decreased proliferation rate compared to monolayer culture, we analyzed the growth kinetics of up to 10 days using the flow cytometric BrdU/Hoechst quenching technique. 30 A 24-h BrdU pulse at the end of the culture period was applied to identify proliferating cells by BrdU-dependent Hoechst dye quenching. Region 1 of the dot plots in Figure 5 reveals that in monolayer culture, only 0.8% of the cells did not exit the G1 phase. On the contrary, in spheroids generated from 10,000 cells and grown for 1, 5, and 10 days, the noncycling G1phase fractions increased from 26.4% to 67.7% and 76.0%, respectively. For spheroids generated by centrifugation with only 1000 cells, the number of noncycling G1-phase cells is slightly lower, indicating improved nutrient and growth factor supply (1-, 5-, and 10-day spheroids: 26.6%, 43.3%, and 66.1% noncycling cells, respectively; FACS plots not shown). The number of cells having divided within 24 h of the BrdU pulse were gated in R3 of Figure 5 . The quantiative results shown at the bottom of Figure 5 indicate a rapid drop in dividing cells within the first 2 days of the spheroid culture. In subconfluent monolayer cultures, the proportion of dividing cells from day 1 through day 3 is between 55% and 65% of the total population. Most important, the BrdU/Hoechst-PI dot plots reveal that the dying cell fractions, located primarily in the center of the spheroids (see Fig. 8 ), originate from the growth-arrested, noncycling G1-phase population as evident by the sub-G1 lane in Figure 5 (see arrows).
Generation of homogenous spheroids from aggregates
We tested the ability of rBM to promote spheroid formation in a variety of breast cancer cell lines that failed to establish a compact morphology when grown in 3D suspension culture after 24 h ( Fig. 1E-H) . Like in MDA-MB-231 cells (Fig. 3) , the addition of liquid rBM to the culture medium induced spheroid formation from aggregates of MDA-MB-468 and SK-BR-3 cells (Fig. 6A, B) . The 3D structure of MDA-MB-435 and MDA-MB-361 cells also became tighter in the presence of rBM (Fig. 6C, D) . The microscopic inspection of spheroid morphology in round-versus conical-bottom 96-well plates revealed that the overall density was slightly higher for some cell lines in conical-bottom wells (data not shown).
To evaluate the homogeneity of single-well spheroids, we quantitated their sizes by microscopic analysis. Spheroids were generated from 8 breast cancer cell lines using 96-well, conicalbottom, poly-HEMA-coated plates. Five thousand cells were centrifuged in RPMI 1640 with 10% FCS and 2.5% rBM, and spheroid size was analyzed after a 24-h culture period. Figure 7 shows typical examples of 6 spheroids each generated from MDA-MB-231 and MCF7 cells, respectively. All spheroids are regular in shape, display a uniform round geometry, and exhibit a narrow size variation. The spheroid volumes were calculated using the geometric mean of 2 orthogonal diameters. Depending on the cell line, the volume of the spheroids formed 24 h after centrifugation from 5000 cells per well ranged from 0.039 to 0.219 mm 3 ( Table 1 ). The homogeneity of the spheroid size is reflected by a small standard deviation ranging from 0.002 to 0.034 mm 3 of the mean. We also observed that cell types such as MDA-MB-231, MDA-MB-468, MDA-MB-435, T-47D, SK-BR3, and MCF7-ADR formed spherical spheroids, with the z axis having a mean value of 102% of the x-/y-axis value, whereas MCF7 and MDA-MB-361 cells tended to exhibited a more elliptic structure in suspension culture, with the z axis being approximately 45% of the x and y axes.
Cell viability of spheroid cells
To investigate the accumulation and localization of dead cells in spheroids generated by centrifugation in rBM-supplemented medium, we analyzed MDA-MB-231 spheroids by performing a microscopic inspection of PI-labeled dead cells. As evident from Figure 8A and B, the rim of the spheroids consists of PI-negative, viable cells only. As early as 24 h, however, dead cells were detectable in the center region of the spheroid (Fig. 8A) . The core region of PI-positive, dead cells increased significantly in 10-day-old spheroids (Fig. 8B) .
Because the viability of cells in 3D culture might change after rBM-induced aggregate compaction, we compared the amount of viable cells in the spheroids grown with and without rBM after 1, 2, 3, 4, 6, and 10 days of culture. Spheroids were disintegrated into single cells, and viable versus apoptotic versus dead cell analysis was performed by annexin-V-fluos/PI staining and flow cytometric analysis. Figure 8 shows typical examples of flow cytometric annexin-V-fluos/PI dot plots of MDA-MB-231 spheroids in the presence of 2.5% rBM after a 24-h ( Fig. 8C) and a 10-day ( Fig. 8D) culture period. The time kinetics of cell viability in 8 different breast cancer spheroids cultured with or without rBM is shown in Figure 8E . Except MDA-MB 231 and MDA-MB 468, the viability was not significantly altered regardless of whether cells were grown in the presence or absence of rBM. The cell viability in spheroids decreases at low rates continuously until a 6-day culture period, with a steep decrease thereafter in MCF7-ADR, MDA-MB 435, and MDA-MB 361 spheroids. Both MCF7 and T47-D cells, which generate tightly packed spheroids even in the absence of rBM, exhibit an initial higher death rate. rBM itself showed no significant toxic effects with any of the breast cancer cell lines when grown in 2D cultures (data not shown).
However, because there is still a significant proliferating cell fraction with the spheroids at each time point (Fig. 5) , we investigated the alteration of the absolute number of viable cells. As a representative example, we investigated MDA-MB 231 spheroids and analyzed the total number of viable cells at the beginning and end of the culture period (for each time point, 4 pooled spheroids). Despite a decline of the percentage of viable cells from 80% (viable/total cells, 16,094/20,118) to 77% (viable/total cells, 25,470/33,078) to 64% (viable/total cells, 44,674/69,803) after a 1-, 3-, and 10-day culture period, respectively, it is evident that the total number of viable cells is even higher at the end of the culture period.
Suspension microplate spheroids from non-breast cancer cell lines
We tested the universal applicability of the microplate, singlewell suspension spheroid generation in a wide range of non-breast cancer cell lines using poly-HEMA-coated, 96-well plates. As evident from Figure 9 , HEK293 cells formed spheroids even in the absence of rBM (Fig. 9A, upper and lower row) .
In contrast, IGROV-1, A549, Colo 205, HepG2, and PC-3 cells form loose aggregates in 3D ( Fig. 9B-F, upper row) . However, rBM induces spheroid formation in all these cells lines, giving rise to compact single spheroids in individual wells ( Fig. 9, lower  row) . Table 2 summarizes the 3D morphological growth characteristics of the different cell lines tested, after a 24-h culture period. Nine of 12 cell lines tested forming aggregates in 3D culture can be transformed to compact spheroids using rBM.
DISCUSSION
Because of their 2D cellular assembly, the physiological phenotype of tumor cells in monolayer cultures differs significantly from their counterparts cultivated in 3D structures. One of the major physiological differences is the establishment of molecule diffusion gradients in 3D cultures. Although the in vivo tumor complexity with numerous different cell types cannot be completely mimicked by spheroids, the tumor vessel distal regions can be simulated by multicellular tumor spheroids. 1 Various culture techniques exist to generate in vitro spheroids in suspension. [25] [26] [27] [28] [29] However, they are not suitable for a standardized, rapid, and large-scale production of spheroids in a format needed for HT assays. Large numbers of spheroids can be generated by the liquid overlay and spinner flask method; however, the formation requires long cultivation times and the spheroids are heterogeneous in size. Importantly, the latter aspect increases the variation of the physiological response pattern because of different sizes of diffusion gradients of, for example, inhibitory/ activating molecules, nutrients, or metabolites, which contributes to the variability of cell physiological and biochemical analyses. The growth of single cells in semisolid medium for spheroid generation also exhibits significant limitations: It is a colony formation and not a true spheroid assay, the culture periods are prolonged, and drug interaction studies are limited (e.g., no pulse chase experiments can be performed). Moreover, biochemical or cellular analyses require difficult recovery of spheroids from semisolid medium.
The method described in this report uses a rapid and simple protocol for reproducible large-scale spheroid production from a large number of tumor cell lines. Single spheroids of equal size and similar geometry can be generated in suspension in a 96-well format within 24 h of cultivation (Fig. 7) . The spheroids generated in suspension by centrifugation retain typical spheroid characteristics such as stratified composition with viable cells in the rim and accumulation of necrotic/apoptotic cells in the center (Fig. 8A, B) . Because the sub-G1 fraction of dead cells exclusively originates The morphology of the spheroids was assessed microscopically by phase-contrast imaging before and after the supplementation of the medium with 2.5% rBM in poly-HEMA-coated, 96-well plates after a 24-h culture period.
from the arrested G1-phase population (Fig. 5, arrows) , it is obvious that the proliferating cell fractions are located mainly in the rim of the spheroids. In addition, stratification is also evident physiologically because the hypoxia-element-driven GFP expression in transfected tumor spheroids is found only within a ring limited by the rim of GFP-negative, nonhypoxic cells on the outside and dead, GFP-negative cells in the core region (data not shown).
Until now, we have generated single-well spheroids from 20 different tumor cell lines (Tables 1 and 2) . Moreover, to mimic different stages of avascular tumor regions, the size of the spheroids can be adjusted to experimental needs by seeding different cell numbers per well prior to centrifugation: small spheroids containing primarily viable cells at the rim and core region and large spheroids harboring larger apoptotic/necrotic areas in the center. 12 Single spheroids can be established in 96-well plates with round-or conical-bottom wells, although centrifugationdependent assembly of cells is slightly superior in conicalshaped wells. In addition, another major advantage of this suspension cell culture format of single spheroids is the ease of mechanical access and transfer to any plate or cell culture vessel format for further cultivation or analysis.
Because of diffusion limitations, death rates in spheroids are higher compared to 2D cell cultures. Compared to a cell viability of >95% of the 2D cultures, our xenograft 3D cell models exhibit either high initial death rates (MCF7, T47-D), low but constant death rates throughout the observation period (MDA-MB-231, MDA-MB-468, SK-BR3), or increased death rates at late time points of spheroid culture (MDA-MB-435, MDA-MB-361, MCF7-ADR). The rBM-induced compaction of the aggregates to spheroids did not increase the cell death rates in the breast cancer cell lines in general. Only in the MDA-MB-231 and MDA-MB-468 cell lines did we observe a 15% to 20% lower viability (Fig. 8) . Because rBM did not affect cell viability in 2D cultures (data not shown), it can be applied as a nontoxic medium supplement in many different tumor cell lines to induce the transition from aggregates to spheroids (e.g., Fig. 9 ). Most likely, cell viability in the spheroid might be significantly affected by the 3D microenvironment of multicellular contacts such as the expression of tight junction molecules, which establish a diffusion barrier for nutrients and oxygen. 31 A current limitation of the spheroid application in vitro is that numerous cancer cell lines do not form compact round spheroids in 3D. 1, 20 For example, approximately half of the breast cancer cell lines tested in this study grew as aggregates of cells in 3D culture (Fig. 1) , an architecture that differs from the compact in vivo cell-cell association of xenograft tumors. Fibronectin in its physiological dimeric conformation can induce aggregation, compaction, and subsequently spheroid formation in CHO cells. 32, 33 Plasmin/urokinase from aged serum was shown to induce spheroid formation in suspension from MCF7 and ZR-75-1 cells. 34 However, the universal use of these proteins for spheroid compaction in a large number of cell lines has not been confirmed in our studies. Our supplementation experiments with different extracellular adhesion molecules indicate that the extract of rBM is superior over fibronectin, laminin, collagen, or proteoglycans alone or in combination (Fig. 2) . The rBMinduced compaction of the aggregates occurred rapidly within 24 h without alteration of the cell culture medium viscosity. The more widespread application of our rBM-induced aggregate/ spheroid transformation in suspension culture in single wells has been shown by its applicability to 9 of 12 non-breast tumor cell models ( Table 2) . Finally, because rBM is an extract of the basement membrane of a murine tumor, it also mimics more closely the in vivo xenograft growth environment of human tumor cells in mice.
In summary, with the method described, we provide a technique for spheroid generation from a large number of different tumor cell lines with several-fold advantages to previous reported methods: simple technique, rapid generation (24 h), production of large spheroid numbers (96-well plate format), single spheroids in suspension (easy accessibility), and morphological homogeneity (little biological variability). Our microplate centrifugation technique requires only poly-HEMA-coated wells and, dependent on the cell type, rBM for generation of spheroids from aggregateforming tumor cells. These suspension culture spheroids are applicable in an HT format for cellular and biochemical assays to analyze the impact of cytotoxic drugs, recombinant proteins, gene therapies, or the cellular microenvironment on proliferation, apoptosis, and gene expression in oncological relevant cell models.
